Track topics on Twitter Track topics that are important to you
YARDLEY, Pa.–(BUSINESS WIRE)–Vensun Pharmaceuticals, Inc. (“Vensun” or “the Company”), a privately held generic pharmaceuticals company, today announced the completion of $22.5 million Series C preferred financing with a consortium of investors led by Perceptive Advisors, LLC. Deerfield Management Company, L.P. … Continue reading
Cet article Vensun Pharmaceuticals, Inc. Completes Series C Financing est apparu en premier sur Biotech 365.
Original Article: Vensun Pharmaceuticals, Inc. Completes Series C FinancingNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...